Rita M. Braziel

23.3k total citations
99 papers, 4.3k citations indexed

About

Rita M. Braziel is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Rita M. Braziel has authored 99 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Pathology and Forensic Medicine, 35 papers in Genetics and 31 papers in Oncology. Recurrent topics in Rita M. Braziel's work include Lymphoma Diagnosis and Treatment (69 papers), Chronic Lymphocytic Leukemia Research (27 papers) and Viral-associated cancers and disorders (19 papers). Rita M. Braziel is often cited by papers focused on Lymphoma Diagnosis and Treatment (69 papers), Chronic Lymphocytic Leukemia Research (27 papers) and Viral-associated cancers and disorders (19 papers). Rita M. Braziel collaborates with scholars based in United States, Germany and Canada. Rita M. Braziel's co-authors include Elaine S. Jaffe, L. Jeffrey Medeiros, Michael LeBlanc, Oliver W. Press, David G. Maloney, Justine R. Smith, Richard I. Fisher, Joseph M. Unger, Thomas P. Miller and Bruce W. Dana and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Rita M. Braziel

99 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rita M. Braziel United States 37 2.7k 1.6k 1.4k 858 668 99 4.3k
Stefano Ascani Italy 32 2.1k 0.8× 1.6k 1.0× 783 0.5× 545 0.6× 757 1.1× 181 4.0k
Karen Pulford United Kingdom 27 2.5k 0.9× 1.5k 1.0× 700 0.5× 737 0.9× 825 1.2× 49 4.2k
Philip M. Kluin Netherlands 47 3.1k 1.2× 2.3k 1.5× 1.5k 1.1× 647 0.8× 1.6k 2.4× 130 6.8k
Dana A. Kennedy United States 24 3.0k 1.1× 2.8k 1.8× 761 0.5× 823 1.0× 887 1.3× 50 4.5k
Robert Chen United States 31 3.1k 1.1× 3.4k 2.1× 939 0.7× 1.1k 1.3× 963 1.4× 81 4.7k
David Y. Mason United Kingdom 40 4.0k 1.5× 2.4k 1.5× 1.3k 0.9× 863 1.0× 1.5k 2.2× 103 6.2k
Michelle A. Fanale United States 36 4.1k 1.5× 3.9k 2.4× 1.2k 0.8× 1.2k 1.4× 1.4k 2.0× 252 6.4k
Douglas E. Horsman Canada 40 3.2k 1.2× 2.6k 1.6× 1.8k 1.2× 545 0.6× 891 1.3× 115 6.4k
Gunilla Enblad Sweden 38 3.0k 1.1× 2.3k 1.5× 1.4k 1.0× 486 0.6× 1.8k 2.7× 200 5.3k
Jan Delabie Norway 48 4.7k 1.7× 3.2k 2.0× 1.9k 1.3× 733 0.9× 1.7k 2.6× 201 7.0k

Countries citing papers authored by Rita M. Braziel

Since Specialization
Citations

This map shows the geographic impact of Rita M. Braziel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita M. Braziel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita M. Braziel more than expected).

Fields of papers citing papers by Rita M. Braziel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita M. Braziel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita M. Braziel. The network helps show where Rita M. Braziel may publish in the future.

Co-authorship network of co-authors of Rita M. Braziel

This figure shows the co-authorship network connecting the top 25 collaborators of Rita M. Braziel. A scholar is included among the top collaborators of Rita M. Braziel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita M. Braziel. Rita M. Braziel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Press, Oliver W., Joseph M. Unger, Lisa M. Rimsza, et al.. (2013). A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab. Clinical Cancer Research. 19(23). 6624–6632. 32 indexed citations
3.
Press, Oliver W., Joseph M. Unger, Lisa M. Rimsza, et al.. (2012). Phase III Randomized Intergroup Trial of CHOP Plus Rituximab Compared With CHOP Chemotherapy Plus 131 Iodine-Tositumomab for Previously Untreated Follicular Non-Hodgkin Lymphoma: SWOG S0016. Journal of Clinical Oncology. 31(3). 314–320. 123 indexed citations
4.
Ramkumar, Hema L., De Fen Shen, Jingsheng Tuo, et al.. (2012). IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas. Graefe s Archive for Clinical and Experimental Ophthalmology. 250(10). 1541–1548. 19 indexed citations
5.
Meyer, Paul N., Kai Fu, Timothy C. Greiner, et al.. (2010). The Stromal Cell Marker SPARC Predicts for Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab. American Journal of Clinical Pathology. 135(1). 54–61. 52 indexed citations
6.
Rimsza, Lisa M., Michael LeBlanc, Joseph M. Unger, et al.. (2008). Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP. Blood. 112(8). 3425–3433. 108 indexed citations
7.
Smith, Justine R., et al.. (2007). Expression of vascular endothelial growth factor and its receptors in rosacea. British Journal of Ophthalmology. 91(2). 226–229. 75 indexed citations
8.
Smith, Justine R., et al.. (2007). Malignant B Cells From Patients With Primary Central Nervous System Lymphoma Express Stromal Cell–Derived Factor-1. American Journal of Clinical Pathology. 127(4). 633–641. 41 indexed citations
9.
Zhong, Yanping, Antony C. Bakke, Guang Fan, et al.. (2007). Drug resistance in B‐cell chronic lymphocytic leukemia: Predictable by in vitro evaluation with a multiparameter flow cytometric cytotoxicity assay. Cytometry Part B Clinical Cytometry. 72B(3). 189–195. 6 indexed citations
10.
11.
Huang, James, Guang Fan, Yanping Zhong, et al.. (2005). Diagnostic Usefulness of Aberrant CD22 Expression in Differentiating Neoplastic Cells of B-Cell Chronic Lymphoproliferative Disorders From Admixed Benign B Cells in Four-Color Multiparameter Flow Cytometry. American Journal of Clinical Pathology. 123(6). 826–832. 15 indexed citations
12.
Maloney, David G., Joseph M. Unger, Rita M. Braziel, et al.. (2004). Fcγ Receptor Polymorphisms Do Not Influence Progression Free Survival (PFS) of Follicular NHL Pateints Treated with Chop Followed by Rituximab (SWOG 9800).. Blood. 104(11). 589–589. 8 indexed citations
13.
14.
Neiman, Richard S., et al.. (2003). Comparison of Fascin Expression in Anaplastic Large Cell Lymphoma and Hodgkin Disease. American Journal of Clinical Pathology. 119(2). 199–204. 2 indexed citations
15.
Hsi, Eric D., Raymond R. Tubbs, Mark A. Lovell, Rita M. Braziel, & Margaret L. Gulley. (2002). Detection of bcl -2/JH Translocation by Polymerase Chain Reaction. Archives of Pathology & Laboratory Medicine. 126(8). 902–908. 7 indexed citations
16.
Bagg, Adam, Rita M. Braziel, Daniel A. Arber, Karen E. Bijwaard, & Albert Y. Chu. (2002). Immunoglobulin Heavy Chain Gene Analysis in Lymphomas. Journal of Molecular Diagnostics. 4(2). 81–89. 71 indexed citations
17.
Gross, Neil D., David J. Wilson, Roger A. Dailey, Jay H. Beckstead, & Rita M. Braziel. (1998). Nodular Sclerosing Hodgkin Disease With Primary Manifestation in the Orbit. Ophthalmic Plastic and Reconstructive Surgery. 14(3). 169–173. 5 indexed citations
18.
Davidson, Michael, Rita M. Braziel, Michael D. Lairmore, et al.. (1993). Atypical human T-cell lymphotropic virus type-I-associated T-cell lymphoma in a low-prevalence alaska native population. Implications for Disease Surveillance. Cancer. 71(12). 4072–4076. 2 indexed citations
19.
Keeffe, Emmet B., et al.. (1989). Colonic lymphoma in the transplant patient. Digestive Diseases and Sciences. 34(1). 150–154. 14 indexed citations
20.
Donohue, John H., Michael T. Lotze, R J Robb, et al.. (1984). In vivo administration of purified Jurkat-derived interleukin 2 in mice.. PubMed. 44(4). 1380–6. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefano Ascani Breakdown of academic impact, for papers by Karen Pulford Breakdown of academic impact, for papers by Philip M. Kluin Breakdown of academic impact, for papers by Dana A. Kennedy Breakdown of academic impact, for papers by Robert Chen Breakdown of academic impact, for papers by David Y. Mason Breakdown of academic impact, for papers by Michelle A. Fanale Breakdown of academic impact, for papers by Douglas E. Horsman Breakdown of academic impact, for papers by Gunilla Enblad Breakdown of academic impact, for papers by Jan Delabie
Rankless by CCL
2026